Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 156-51-4 Chemical Structure| 156-51-4

Structure of Phenelzine sulfate
CAS No.: 156-51-4

Chemical Structure| 156-51-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Phenelzine sulfate is a non-selective and irreversible monoamine oxidase inhibitor (MAOI), used as an antidepressant and anxiolytic.

Synonyms: Phenelzine (sulfate); W-1544A; NSC 170957

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Phenelzine sulfate

CAS No. :156-51-4
Formula : C8H14N2O4S
M.W : 234.27
SMILES Code : NNCCC1=CC=CC=C1.O=S(O)(O)=O
Synonyms :
Phenelzine (sulfate); W-1544A; NSC 170957
MDL No. :MFCD00050687

Safety of Phenelzine sulfate

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301
Precautionary Statements:P280-P305+P351+P338
Class:6.1
UN#:2811
Packing Group:

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01944657 1. Major Depressive Disorder Not Applicable Withdrawn(unable to enroll sub... More >>jects) Less << December 2015 United States, Maryland ... More >> Sheppard Pratt Health System Towson, Maryland, United States, 21204 Less <<
NCT01253642 Hormone-Resistant Prostate Can... More >>cer Metastatic Prostatic Adenocarcinoma Prostate Adenocarcinoma Recurrent Prostate Carcinoma Less << Phase 2 Terminated(low enrollment) - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 Less <<
NCT01253642 - Terminated(low enrollment) - -
NCT02217709 Adenocarcinoma of the Prostate... More >> Recurrent Prostate Cancer Stage I Prostate Cancer Stage IIA Prostate Cancer Stage IIB Prostate Cancer Stage III Prostate Cancer Less << Phase 2 Recruiting September 8, 2020 United States, California ... More >> USC Norris Westside Cancer Center Recruiting Beverly Hills, California, United States, 90211 Contact: Olga Castellanos    310-272-7653    ocastell@usc.edu    Principal Investigator: Mitchell E. Gross          Los Angeles County-USC Medical Center Recruiting Los Angeles, California, United States, 90033 Contact: Bartolo Santos, RN    323-409-4363    Bartolo.santos@med.usc.edu    Principal Investigator: Mitchell E. Gross, MD          Principal Investigator: Jean C. Shih, PhD          USC Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Charis Barg, RN    323-865-0464    Charis.barg@med.usc.edu    Principal Investigator: Mitchell E. Gross, MD          Principal Investigator: Jean C. Shih, PhD          Keck Medical Center of USC Pasadena Recruiting Pasadena, California, United States, 91105 Contact: Charis Barg, RN    323-865-0464    Charis.barg@med.usc.edu    Principal Investigator: Mitchell E. Gross, MD          Principal Investigator: Jean C. Shih, MD Less <<
NCT03505528 Metastatic Breast Cancer Phase 1 Recruiting May 20, 2019 Australia, Australian Capital ... More >>Territory Canberra Region Cancer Centre Recruiting Canberra, Australian Capital Territory, Australia, 260 Contact: Desmond Yip, MBBS    +61 2 6244 2220    desmond.yip@act.gov.au    Contact: Laeeq Malik, MBBS    +61 2 6244 2220    laeeq.malik@act.gov.au    Australia, New South Wales Southern Medical Day Care Centre Recruiting Wollongong, New South Wales, Australia, 2500 Contact: Philip Clingan, MBBS    +61 2 4227 3733    philipc@uow.edu.au    Contact: Margaret Clingan    +61 2 4227 3733    margaret@smdcc.com.au Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.27mL

0.85mL

0.43mL

21.34mL

4.27mL

2.13mL

42.69mL

8.54mL

4.27mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories